Introductions to the latest additions to the AMS website are shown here.
Members should log in to see the Members's only content on this page.
-
Climara 50mcg Patch Shortage
The Therapeutic Goods Administration (TGA) have reported an anticipated shortage of CLIMARA 50 mcg transdermal patches with supply due to return on 31 July 2018. Read more. -
Diet and the start of the menopause
In the first UK study examining the relationship between diet and the start of the menopause researchers have found certain food groups could affect the age at which the menopause begins. Research by the University of Leeds has examined the links between diet and the onset of menopause in British w... Read more. -
Anxiety and bone health
Higher levels of anxiety increase fracture risk in postmenopausal women. Anxiety has already been shown to take its toll on the human body in many ways, including increased risk for heart disease and gastrointestinal disorders. Now a new study demonstrates how anxiety levels are linked to an increa... Read more. -
Severity of menopause symptoms could help predict heart disease
Heart disease remains the leading cause of death in women. A study of 138 menopausal women examined the association of mood, symptoms, and quality of life measures with the key markers of vascular aging, a major risk factor for the development of cardiovascular disease (CVD). Study results were publ... Read more. -
ESHRE Companion guidelines on the management of premature ovarian insufficiency
The European Society of Human Reproduction and Embryology (ESHRE) guideline offers best practice advice on the care of women with premature ovarian insufficiency (POI), both primary and secondary. The patient population comprises women younger than 40 years (which includes Turner Syn... Read more. -
Does age at menopause affect memory?
Entering menopause at a later age may be associated with a small benefit to your memory years later, according to a study published in Neurology®, the medical journal of the American Academy of Neurology. "This study suggests that lifelong hormonal processes, not just short-term fluctuations during... Read more. -
Does menopausal hormone therapy maintain the brain?
Taking menopausal hormone therapy soon after menopause to relieve symptoms may also benefit the brain, according to a study published in the March 21, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology. "We found that one form of menopausal hormone thera... Read more. -
Stem cell therapy may help reverse effects of premature menopause, restore fertility
Young women with premature ovarian insufficiency (POI) may be able to use their own bone marrow stem cells to rejuvenate their ovaries and avoid the effects of premature menopause, new research suggests. The preliminary results from the ongoing ROSE clinical trial were presented at ENDO 2018, the 10... Read more. -
Mediterranean diet is linked to higher muscle mass, bone density after menopause
The heart-healthy Mediterranean diet also appears to be good for an older woman's bones and muscles, a new study of postmenopausal women in Brazil finds. The study results will be presented Monday at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill. The researchers reported f... Read more. -
Reducing the number and severity of hot flushes: new class of menopause drugs
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The treatment, tested by scientists at Imperial College London, also reduces the severity of hot flushes by over a third within three days of taking it. The research, funded by th... Read more. -
Menopausal hormone therapy linked to having a healthier heart
Women who use menopausal hormone therapy appear to have a heart structure and function that is linked to a lower risk of heart failure, according to a study led by Queen Mary University of London. The effect of menopausal hormone therapy (MHT), previously known as hormone replacement therapy, on ca... Read more. -
Cervical screening participation rates - what influences them
The impression that foreign-born women in Sweden more often are excluded from gynecological cancer screening needs to be reconsidered. A study from Sahlgrenska Academy, published in the journal PLOS One, makes it clear that foreign-born women participate to the same extent as women born in Sweden wi... Read more. -
Increased risk of heart disease after hysterectomy
In an effort to reduce the associated increased risk of heart disease after hysterectomy, more surgeons are opting to leave a woman's ovaries intact. However, a study shows that women (especially those aged younger than 35 years) having a hysterectomy with ovarian conservation are still at increased... Read more. -
Heavy Menstrual Bleeding Clinical Care Standard launched
7 December 2017: Women to benefit from first national treatment standard for heavy periods The first nationally agreed standard of care for women experiencing heavy menstrual bleeding says women should be offered less invasive treatments before considering a hysterectomy – a major op... Read more. -
Oestrogen patch update - supply returned
30 November 2017: Novartis has advised that the company has both received and released stock for supply locally of the following lines; ESTALIS CONT 50+140MCG ESTALIS SEQ 50MCG/50+ 140MCG ESTALIS SEQ 50MCG/50+ 250MCG As a result the only remaining HRT line now still u... Read more. -
Women's memory may benefit from hormone replacement therapy
A type of hormone replacement therapy may protect memory for some women, according to an American study. The research findings are the latest to indicate that hormone replacement therapy may have some benefits, deepening scientific discussions about the pros and cons of the menopausal treatment. "... Read more. -
Discontinuing hormone therapy increases risk of cardiac and stroke death
Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A European study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Since publication ... Read more. -
Postmenopausal obesity redefined
BMI may not be valid measure of obesity status in older adults There is no doubt the prevalence of obesity has increased significantly across all age groups, creating greater health risks. What exactly constitutes obesity, however, is subject to debate, especially for postmenopausal women who ... Read more. -
Prasterone (Intrarosa) for Dyspareunia
From the Medical Letter The FDA has approved the steroid prasterone (Intrarosa – Endoceutics) for intravaginal treatment of postmenopausal women with moderate-to-severe dyspareunia due to vulvovaginal atrophy (VVA) (Table 1). Also called dehydroepiandrosterone (DHEA), prasterone is produced in the ... Read more. -
Bioidentical Hormones - risks revisited
The October issue of Endocrine news (1) carries an article that once again tackles the complexity of bioidentical hormones. The freelance US writer highlights the confusion surrounding "bioidentical hormones" and more specifically the compounded formulations that are promoted as "natural". Th... Read more.
